Rehabilitation Enhanced by Partial Arterial Inflow Restrictions (REPAIR)

December 22, 2023 updated by: Major Extremity Trauma Research Consortium

REPAIR: Rehabilitation Enhanced by Partial Arterial Inflow Restrictions

The Rehabilitation Enhanced by Partial Arterial Inflow Restriction (REPAIR) Study will be conducted in a patient population of individuals recovering from a traumatic diaphyseal fracture of the femur. Although the intervention can be used for any patient with muscle weakness following trauma, the persistent thigh weakness that follows a femur fracture provides a perfect model for evaluating the effectiveness of the REPAIR protocol.

Study Overview

Status

Active, not recruiting

Study Type

Interventional

Enrollment (Estimated)

250

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Indiana
      • Indianapolis, Indiana, United States, 46202
        • Methodist Hospital
    • Maryland
      • Baltimore, Maryland, United States, 21201
        • University of Maryland Medical Center
      • Bethesda, Maryland, United States, 20889
        • Walter Reed National Military Medical Center
    • Missouri
      • Saint Louis, Missouri, United States, 63110
        • Barnes Jewish Hospital
    • North Carolina
      • Charlotte, North Carolina, United States, 28204
        • Carolinas Medical Center
    • Ohio
      • Cleveland, Ohio, United States, 44109
        • MetroHealth
    • Texas
      • Houston, Texas, United States, 77030
        • University of Texas Health Science Center at Houston
      • San Antonio, Texas, United States, 78219
        • San Antonio Military Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 55 years (Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Adults ages 18-55 inclusive
  2. Admitted to one of the participating clinical centers for operative treatment of a closed diaphyseal femur fracture with one of the following OTA codes: 32A, 32B or 32C (treated with an IM Nail).

Exclusion Criteria:

  1. Open diaphyseal femur fracture (except low velocity gunshot wounds) or severe crushing injuries to study limb.
  2. Additional fracture, dislocations or soft tissue injuries to the study limb that would compromise the ability to weight bear as tolerated and initiate PT within 28 days of definitive fixation.
  3. Any fractures, dislocations or soft tissue injuries to the contralateral limb or pelvis that would compromise the ability to weight bear as tolerated and initiate PT within 28 days of definitive fixation.
  4. Any treatment of the study injury in either group that would preclude application of the tourniquet cuff (e.g. vascular reconstruction, wound, flap, or skin graft).
  5. Injuries to other body systems (or other medical conditions) that would preclude the ability to weight bear as tolerated and initiate PT within 28 days of definitive fixation (e.g. spinal cord deficit; severe traumatic brain injury).
  6. Use of blood flow restriction (BFR) at any time between treatment and the start of physical therapy for the study.
  7. Non-ambulatory pre-injury.
  8. Morbidly obese (BMI > 40).
  9. History of Peripheral Artery Disease and/or Peripheral Vascular Disease (PAD/PVD).
  10. Current or history of venous thromboembolism.
  11. Impaired circulation or peripheral vascular compromise.
  12. Previous revascularization at the study injury site.
  13. Extremities with dialysis access.
  14. Current diagnosis of acidosis.
  15. Diagnosis of sickle cell anemia.
  16. Current infection of the study injury.
  17. Current tumor (malignant or benign) distal to study injury and future tourniquet placement.
  18. Current use of medications or supplements that are known to increase clotting risk.
  19. Diagnosis of severe hypertension (blood pressure of 180/110).
  20. Skin grafts in which all bleeding points must be readily distinguished.
  21. Secondary or delayed surgical procedures to study injury after immobilization.
  22. Vascular grafting to the study injury.
  23. History of lymphotomies.
  24. Current diagnosis of cancer.
  25. Unable to speak either English or Spanish.
  26. Severe problems with maintaining follow-up (e.g. patients who are prisoners, homeless at the time of injury, who are intellectually challenged without adequate family support, or have document psychiatric disorders).
  27. Unable to provide informed consent.
  28. Patient has not been cleared to start physical therapy at the time of consent.
  29. Patient is pregnant.
  30. Patient received BFR between date of injury and start of Physical Therapy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Standard of Care Physical Therapy
This group will receive the standard of care physical therapy program for 6 weeks.
Experimental: Blood Flow Restriction Plus Standard of Care Physical Therapy
This group will receive the same standard of care physical therapy program for 6 weeks plus blood flow restriction.
Brief and intermittent blood flow restriction via a Delfi PTSII Tourniquet System will be used during physical therapy.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knee Strength measured using a stabilized hand held dynamometer
Time Frame: up to 6 months
Knee strength will be measured using a stabilized hand held dynamometer in both the injured and uninjured legs.
up to 6 months
Muscle Volume assessed using mid-thigh girth circumference measurement
Time Frame: up to 6 months
Muscle volume will be assessed using mid-thigh girth circumference measurements.
up to 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Strength
Time Frame: up to 6 months
Strength will be measured using the sit to stand test.
up to 6 months
Speed
Time Frame: up to 6 months
Speed will be evaluated using the self selected walking speed.
up to 6 months
Speed
Time Frame: up to 6 months
Speed will be evaluated using the 40 yard shuttle run.
up to 6 months
Posture Stability
Time Frame: Change in Functional Performance Measures at 3 months and 6 months
Postural stability will be evaluated using the single leg stance.
Change in Functional Performance Measures at 3 months and 6 months
Agility
Time Frame: up to 6 months
Agility will be measured using the 4 step square test.
up to 6 months
Agility
Time Frame: up to 6 months
Agility will be measured using the Illinois Agility Test.
up to 6 months
Physical Function
Time Frame: up to 1 year
Physical Function will be evaluated by the Patient Reported Outcomes Measurement Information System physical function questionnaire.
up to 1 year
Depression evaluated with a depression questionnaire
Time Frame: up to 1 year
Depression will be evaluated by the Patient Reported Outcomes Measurement Information System depression questionnaire.
up to 1 year
Anxiety evaluated with an anxiety questionnaire
Time Frame: up to 1 year
Anxiety will be evaluated by the Patient Reported Outcomes Measurement Information System anxiety questionnaire.
up to 1 year
Sleep Disturbance evaluated with a sleep disturbance questionnaire
Time Frame: up to 1 year
Sleep Disturbance will be evaluated by the Patient Reported Outcomes Measurement Information System sleep disturbance questionnaire.
up to 1 year
Psychological outcome-Post Traumatic Stress (PTSD) measured using the standard PTSD Checklist (PCL)
Time Frame: up to 1 year
PTSD will be measured using the standard PTSD Checklist (PCL).
up to 1 year
Return to Work and Work Productivity measured using the Work Productivity and Activity Impairment (WPAI) questionnaire
Time Frame: up to 1 year
Work productivity will be measured using the Work Productivity and Activity Impairment (WPAI) questionnaire.
up to 1 year
Pain evaluated with a Pain Inference scale
Time Frame: up to 1 year
Pain will be evaluated by the Patient Reported Outcomes Measurement Information System Pain Inference scale.
up to 1 year
Satisfaction with Care and Recovery assessed using the MedRisk Instrument for Measuring Patient Satisfaction with Physical Therapy Care (MRPS)
Time Frame: 3 months
This will be assessed using the MedRisk Instrument for Measuring Patient Satisfaction with Physical Therapy Care (MRPS).
3 months
Fracture Healing
Time Frame: up to 1 year
Fracture healing will be determined by clinical examinations.
up to 1 year
Fracture Healing
Time Frame: up to 1 year
Fracture healing will be determined by radiographic examinations.
up to 1 year
Complications
Time Frame: up to 1 year
The presence of all limb related complications will be recorded prospectively at each follow up visit, and categorized according to type, date diagnosed, severity, treatment and relation to the study injury.
up to 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Lisa Reider, PhD, Major Extremity Trauma Research Consortium Coordinating Center
  • Principal Investigator: Daniel J Stinner, MD, San Antonio Military Medical Center
  • Principal Investigator: Ellen J MacKenzie, PhD, Major Extremity Trauma Research Consortium Coordinating Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2016

Primary Completion (Actual)

September 1, 2023

Study Completion (Estimated)

March 1, 2024

Study Registration Dates

First Submitted

April 7, 2016

First Submitted That Met QC Criteria

April 18, 2016

First Posted (Estimated)

April 21, 2016

Study Record Updates

Last Update Posted (Actual)

December 26, 2023

Last Update Submitted That Met QC Criteria

December 22, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Closed Femur Fracture

Clinical Trials on Blood Flow Restriction

3
Subscribe